All Posts

SCYNEXIS Receives FDA Approval for BREXAFEMME, the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Biotech company SCYNEXIS has announced FDA (U.S. Food and Drug Administration) approval of BREXAFEMME (ibrexafungerp tablets) for oral use in patients with vulvovaginal candidiasis (VVC), also known as vaginal yeast infection. BREXAFEMME is the first approved drug in a novel antifungal class in more than 20 years and was approved based on positive results from two Phase 3 studies in which oral ibrexafungerp demonstrated…

Emme Expands Its Birth Control Offering and Launches EmmeRx, a New Prescription Delivery and Telemedicine Service

Femtech startup Emme today announced the launch of EmmeRx, a birth control pill prescription delivery and telemedicine service. EmmeRx builds upon the success of the Emme Smart Case, which has been shown to deliver an 80% reduction in missed birth control pills. The new service is currently available in 16 states. Emme was co-founded in 2017 by Amanda French and Janene Fuerch,…

CCRM Fertility Launches “The F-Word Collection” to Help Destigmatize Fertility

To help remove the stigma around fertility CCRM Fertility has launched The F-Word Collection, an ecommerce shop that features a diverse collection of hand-picked products from women-owned businesses passionate about fertility. The shop is part of a larger campaign by CCRM Fertility to normalize the conversations about fertility and give people an easy way to show their support. Proceeds from the shop…

Ark Surgical Raises $2.1M for its LapBox Tissue Containment System for Laparoscopic GYN Surgery

Israeli femtech startup Ark Surgical has secured $2.1 million in funding for its LapBox containment system for secure removal of large internal organs during laparoscopic GYN surgery. The financing was raised from investors of the Together equity crowdfunding platform alongside the Israeli Innovation Authority and NGT. Ark Surgical has completed the first-in-human (FIH) study demonstrating the safety and effectiveness of the LapBox. Approximately 600,000 hysterectomies…

Psychedelic Biotech Eastra Health Launches with Plans to Address Menopause and PMS

Today saw the launch of Eastra Health, the world’s first female-focused biotech company dedicated to developing psychedelic-derived medicines specifically for women. Eastra Health will offer new solutions for under-addressed health conditions like menstrual pain or menopause through an innovative approach to drug discovery and a deep, holistic understanding of women’s health, biology, and specific needs. “For years, women have been overlooked by…